Arsenic Trioxide and Tretinoin (AsO/ATRA) for Acute Promyelocytic Leukemia (APL)
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
The complexity of cancer chemotherapy requires pharmacists be familiar with the complicated regimens and highly toxic agents used. This column reviews various issues related to preparation, dispensing, and administration of antineoplastic therapy, and the agents, both commercially available and investigational, used to treat malignant diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The FDA has approved ATRA to treat cystic acne and several cancers, such as some lymphoma and leukemia”
From Vitamin A Update: Forms, Sources, Kinetics, Detection, Function, Deficiency, Therapeutic Use and Toxicity (2021) · cites this paper as [347]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The National Comprehensive Cancer Network: Present and future directions
McGivney, W. T. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980515)82:10+<2057::aid-cncr14>3.0.co;2-a · Cited by 16,766
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
Lo-Coco, F., Avvisati, G., Vignetti, M., Thiede, C., Orlando, S. M., Iacobelli, S., Ferrara, F., Fazi, P., Cicconi, L., Di Bona, E., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1300874 · Cited by 1,611
Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update
Basch, E., Prestrud, A. A., Hesketh, P. J., Kris, M. G., Feyer, P. C., Somerfield, M. R., Chesney, M., Clark-Snow, R. A., Flaherty, A. M., Freundlich, B., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.34.4614 · Cited by 1,059
Recommended Guidelines for the Treatment of Cancer Treatment-Induced Diarrhea
Benson, A. B., Ajani, J. A., Catalano, R. B., Engelking, C., Kornblau, S. M., Martenson, J. A., McCallum, R., Mitchell, E. P., O'Dorisio, T. M., Vokes, E. E., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.04.132 · Cited by 631
Proposal for classifying the acute emetogenicity of cancer chemotherapy.
Hesketh, P. J., Kris, M. G., Grunberg, S. M., Beck, T., Hainsworth, J. D., Harker, G., Aapro, M. S., Gandara, D., & Lindley, C. M. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.1.103 · Cited by 605
Shen, Z.-X., Shi, Z.-Z., Fang, J., Gu, B.-W., Li, J.-M., Zhu, Y.-M., Shi, J.-Y., Zheng, P.-Z., Yan, H., Liu, Y.-F., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400053101 · Cited by 583
Burnett, A. K., Russell, N. H., Hills, R. K., Bowen, D., Kell, J., Knapper, S., Morgan, Y. G., Lok, J., Grech, A., Jones, G., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00193-x · Cited by 534
Estey, E., Garcia-Manero, G., Ferrajoli, A., Faderl, S., Verstovsek, S., Jones, D., & Kantarjian, H. (2006) · Blood · doi:10.1182/blood-2005-10-4006 · Cited by 384
Ravandi, F., Estey, E., Jones, D., Faderl, S., O'Brien, S., Fiorentino, J., Pierce, S., Blamble, D., Estrov, Z., Wierda, W., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.6130 · Cited by 376
O'Donnell, M. R., Abboud, C. N., Altman, J., Appelbaum, F. R., Arber, D. A., Attar, E., Borate, U., Coutre, S. E., Damon, L. E., Goorha, S., et al. (2012) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2012.0103 · Cited by 323
Zhu, H.-H., Wu, D.-P., Jin, J., Li, J.-Y., Ma, J., Wang, J.-X., Jiang, H., Chen, S.-J., & Huang, X.-J. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.48.8312 · Cited by 181
Maroun, J. A., Anthony, L. B., Blais, N., Burkes, R., Dowden, S. D., Dranitsaris, G., Samson, B., Shah, A., Thirlwell, M. P., Vincent, M. D., et al. (2007) · Current Oncology · doi:10.3747/co.2007.96 · Cited by 161
Raffoux, E., Rousselot, P., Poupon, J., Daniel, M.-T., Cassinat, B., Delarue, R., Taksin, A.-L., Réa, D., Buzyn, A., Tibi, A., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.01.149 · Cited by 152
Oral Arsenic and Retinoic Acid for Non–High-Risk Acute Promyelocytic Leukemia
Zhu, H., & Huang, X. (2014) · New England Journal of Medicine · doi:10.1056/nejmc1412035 · Cited by 102
Au, W.-Y., Kumana, C. R., Lee, H. K. K., Lin, S.-Y., Liu, H., Yeung, D. Y. M., Lau, J. S. M., & Kwong, Y.-L. (2011) · Blood · doi:10.1182/blood-2011-05-354530 · Cited by 101
Dai, C.-W., Zhang, G., Shen, J.-K., Zheng, W., Pei, M.-F., Xu, Y., Cao, Y., Yi, Y., Yang, J., Peng, H., et al. (2009) · Acta Haematologica · doi:10.1159/000204472 · Cited by 44
Research works printed but not linked: 2
- 2015, Trisenox [prescribing information].
- 2010, Tretinoin, [prescribing information].
Cited by
Carazo, A., Macáková, K., Matoušová, K., Krčmová, L. K., Protti, M., & Mladěnka, P. (2021) · Nutrients · doi:10.3390/nu13051703 · Cited by 461
Repurposing of Acriflavine to Target Chronic Myeloid Leukemia Treatment
Nehme, R., Hallal, R., Dor, M. E., Kobeissy, F. H., Gouilleux, F., Mazurier, F., & Zibara, K. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867327666200908114411 · Cited by 36
How much do we know about the metastatic process?
Rodríguez-Tirado, C., & Sosa, M. S. (2024) · Clinical & Experimental Metastasis · doi:10.1007/s10585-023-10248-0 · Cited by 10
Boush, M., Kiaei, A. A., & Mahboubi, H. (2023) · medRxiv · doi:10.1101/2023.08.17.23294228 · Cited by 5
Kiyaee, A. A., & Tabatabaei, S. G. H. (2024) · Journal of Artificial Intelligence Applications and Innovations · doi:10.61838/jaiai.1.1.4
Metadata
- Authors
- Damery, E., Solimando, D. A., & Waddell, J. A.
- Affiliations
- National Institutes of Health (US)
- Venue
- Hospital Pharmacy
- Publisher
- SAGE Publications
- Published
- 2016-08-01
- Volume
- 51
- Issue
- 8
- Pages
- 628-632
- ISSN
- 0018-5787 (ISSN-L)
- 1945-1253
- PMC
- PMC5030872
- OpenAlex
- W2523289915
- Cited by
- 7
- References
- 16
- Citations by year
- 2026: 3 · 2024: 1 · 2023: 1 · 2021: 1 · 2020: 1
- FWCI
- 0.00
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Hospital Pharmacy (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Health Sciences › Health Professions › Pharmacy › Pharmacy and Medical Practices
- Keywords
- arsenic trioxide, all-trans retinoic acid, acute promyelocytic leukemia, drug preparation, medication administration, chemotherapy toxicity, investigational anticancer agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.